Armstrong World Industries, Inc. (NYSE:AWI) declared that its third quarter earnings of $0.83 a share, $0.05 improved than the Capital IQ Consensus Estimate of $0.78. The firm releases in-line guidance for FY14, sees EPS of $2.00-2.15 vs. $2.09 Capital IQ Consensus Estimate; sees FY14 revs of 2.68B -2.72B as compared to $2.71B Capital IQ Consensus Estimate. Armstrong World Industries, Inc. (NYSE:AWI) stock hit highest price at $48.99, beginning with a price of $48.00 and reported a decrease of -5.49% to the closed at $46.12 with a day range of $45.91-$48.99. The total market capitalization remained 2.529 Billion, total volume of 1.92 Million shares held in the session was surprisingly higher than its average volume of 1005.68 shares.Armstrong World Industries, Inc. (NYSE:AWI) declared that its third quarter adjustment earnings of $0.90 a share, excluding non-recurring items, $0.02 improved than the Capital IQ Consensus Estimate of $0.88. Merck & Co. Inc. (NYSE:MRK) stock has highest price of $57.24 in last session, beginning with a price of $57.185 and reported a lose of -2.01% to the closed at $56.45 with a day range of $55.92-$57.24. The stock is going forward its 52-week low with 30.58% and moving down from its 52 week high price with -7.43%.Sarepta Therapeutics, Inc. (NASDAQ:SRPT) released that it's an update on its discussions with the FDA regarding its planned NDA submission for the authorization of eteplirsen for the treatment of Duchenne muscular dystrophy. In meeting minutes received previous week from a Type B Pre-NDA meeting that took place in September 2014, the FDA provided updated guidance regarding the specific data to be comprised as part of, or at the time of, Sarepta's NDA submission. Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) traded at $15.91 by moving down -32.47% with price volatility of 6.51% for a week and 7.89% for a month. Its beta stands at 0.53 times.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
